Black Stock Analysis

BDTX -  USA Stock  

USD 3.95  0.11  2.86%

The big decline in price over the last few months for Black Diamond Therap could raise concerns from investors as the firm it trading at a share price of 3.95 on 334,629 in volume. The company executives failed to add value to investors and positioning the firm supply of money to exploit market volatility in December. However, diversifying your holdings with Black Diamond Therapeutics or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.22. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Black Diamond partners.
Continue to Trending Equities.

Black Stock Analysis 

 
Refresh
The Black Diamond stock analysis report makes it easy to digest most publicly released information about Black Diamond and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Black Stock analysis module also helps to analyze the Black Diamond price relationship with some important fundamental indicators such as market cap and management efficiency.

Black Stock Analysis Notes

About 85.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.64. Some equities with similar Price to Book (P/B) outperform the market in the long run. Black Diamond Therap recorded a loss per share of 3.39. The entity had not issued any dividends in recent years. Black Diamond Therapeutics, Inc., a biotechnology company, discover and develops small molecule, tumor-agnostic therapies. Black Diamond Therapeutics, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts. Black Diamond operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 69 people. For more info on Black Diamond Therapeutics please contact the company at 617 252 0848 or go to https://www.blackdiamondtherapeutics.com.

Black Diamond Therap Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Black Diamond's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Black Diamond Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Black Diamond Therap generated a negative expected return over the last 90 days
Black Diamond Therap has high historical volatility and very poor performance
Net Loss for the year was (122.36 M).
Black Diamond Therapeutics currently holds about 235.01 M in cash with (91.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.49, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Black Diamond Therap has a frail financial position based on the latest SEC disclosures
Over 85.0% of the company shares are held by institutions such as insurance companies

Black Diamond Therap Upcoming and Recent Events

Earnings reports are used by Black Diamond to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Black Diamond previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report24th of March 2022
Next Earnings Report6th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End24th of March 2022
Last Quarter Report30th of September 2021
Last Earning Announcement31st of December 2020

Black Largest EPS Surprises

Earnings surprises can significantly impact Black Diamond's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-05-07
2021-03-31-0.677-0.84-0.16324 
2020-02-03
2019-12-31-1.37-4.63-3.26237 
View All Earnings Estimates

Black Diamond SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Black Diamond prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Black Diamond investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Black Diamond Therap specific information freely available to individual and institutional investors to make a timely investment decision.
10th of January 2022
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
View
22nd of November 2021
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
8th of November 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
12th of August 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
10th of August 2021
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
5th of August 2021
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
22nd of June 2021
Submission of Matters to a Vote of Security Holders
View
19th of May 2021
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
View

Black Diamond Thematic Classifications

In addition to having Black Diamond stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical Products IdeaPharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French

Black Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Black Diamond is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Black Diamond Therapeutics backward and forwards among themselves. Black Diamond's institutional investor refers to the entity that pools money to purchase Black Diamond's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Ae Wealth Management LlcCommon Shares16.1 K86 K
Koshinski Asset Management IncCommon Shares4002.1 K
Bellevue Group AgCommon Shares3.5 M29.3 M
Nea Management Company LlcCommon Shares3.4 M29.2 M
Ra Capital Management LpCommon Shares2.6 M21.9 M
Blackrock IncCommon Shares2.2 M18.5 M
Boxer Capital LlcCommon SharesM17 M
Note, although Black Diamond's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Black Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 139.12 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Black Diamond's market, we take the total number of its shares issued and multiply it by Black Diamond's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Black Profitablity

Black Diamond's profitability indicators refer to fundamental financial ratios that showcase Black Diamond's ability to generate income relative to its revenue or operating costs. If, let's say, Black Diamond is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Black Diamond's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Black Diamond's profitability requires more research than a typical breakdown of Black Diamond's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Average Assets(0.22) (0.24) 
Return on Average Equity(0.18) (0.18) 
Return on Invested Capital(0.28) (0.29) 

Management Efficiency

The entity has return on total asset (ROA) of (24.97) % which means that it has lost $24.97 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (44.79) %, meaning that it created substantial loss on money invested by shareholders. Black Diamond management efficiency ratios could be used to measure how well black diamond therap manages its routine affairs as well as how well it operates its assets and liabilities. Return on Average Assets is likely to drop to -0.24 in 2022. Return on Invested Capital is likely to drop to -0.29 in 2022. Black Diamond Total Assets are fairly stable at the moment as compared to the past year. Black Diamond reported Total Assets of 379.12 Million in 2021. Current Assets is likely to rise to about 396.5 M in 2022, whereas Return on Average Assets are likely to drop (0.24)  in 2022.
Last ReportedProjected for 2022
Book Value per Share 10.75  11.60 
Enterprise Value over EBIT(14.40) (15.54) 
Enterprise Value over EBITDA(14.79) (15.95) 
Price to Book Value 3.37  3.35 
Tangible Assets Book Value per Share 11.52  11.82 
Enterprise Value993.6 M987.8 M
Tangible Asset Value379.1 M409.1 M

Technical Drivers

As of the 24th of January, Black Diamond shows the mean deviation of 2.87, and Risk Adjusted Performance of (0.19). Black Diamond Therap technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Black Diamond Therapeutics, which can be compared to its rivals. Please confirm Black Diamond Therap standard deviation, as well as the relationship between the value at risk and kurtosis to decide if Black Diamond Therap is priced correctly, providing market reflects its regular price of 3.95 per share. Given that Black Diamond has jensen alpha of (0.93), we suggest you to validate Black Diamond Therapeutics's prevailing market performance to make sure the company can sustain itself at a future point.

Black Diamond Therap Price Movement Analysis

The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to Black Diamond Therap price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator. View also all equity analysis or get more info about mesa adaptive moving average overlap studies indicator.

Black Diamond Therap Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Black Diamond insiders, such as employees or executives, is commonly permitted as long as it does not rely on Black Diamond's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Black Diamond insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Black Diamond Predictive Daily Indicators

Black Diamond intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Black Diamond stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Black Diamond Forecast Models

Black Diamond time-series forecasting models is one of many Black Diamond's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Black Diamond's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Black Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Black Diamond stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Black shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Black Diamond. By using and applying Black Stock analysis, traders can create a robust methodology for identifying Black entry and exit points for their positions.
Black Diamond Therapeutics, Inc., a biotechnology company, discover and develops small molecule, tumor-agnostic therapies. Black Diamond Therapeutics, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts. Black Diamond operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 69 people.

Current Black Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Black analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Black analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
26.6Buy5Odds
Black Diamond Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Black analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Black stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Black Diamond Therap, talking to its executives and customers, or listening to Black conference calls.
Black Analyst Advice Details

Black Stock Analysis Indicators

Black Diamond Therapeutics stock analysis indicators help investors evaluate how Black Diamond stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Black Diamond shares will generate the highest return on investment. By understating and applying Black Diamond stock analysis, traders can identify Black Diamond position entry and exit signals to maximize returns.
Quick Ratio8.91
Fifty Two Week Low3.7800
Shares Short Prior Month3.08M
Average Daily Volume Last 10 Day2.25M
Average Daily Volume In Three Month565.71k
Shares Percent Shares Out8.29%
Short Percent Of Float13.26%
Forward Price Earnings-0.96
Float Shares20.41M
Fifty Two Week High29.6200
Enterprise Value To Ebitda0.17
Fifty Day Average5.7620
Two Hundred Day Average11.3240
Continue to Trending Equities. Note that the Black Diamond Therap information on this page should be used as a complementary analysis to other Black Diamond's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Black Stock analysis

When running Black Diamond Therap price analysis, check to measure Black Diamond's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Black Diamond is operating at the current time. Most of Black Diamond's value examination focuses on studying past and present price action to predict the probability of Black Diamond's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Black Diamond's price. Additionally, you may evaluate how the addition of Black Diamond to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Is Black Diamond's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Black Diamond. If investors know Black will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Black Diamond listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Black Diamond Therap is measured differently than its book value, which is the value of Black that is recorded on the company's balance sheet. Investors also form their own opinion of Black Diamond's value that differs from its market value or its book value, called intrinsic value, which is Black Diamond's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Black Diamond's market value can be influenced by many factors that don't directly affect Black Diamond's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Black Diamond's value and its price as these two are different measures arrived at by different means. Investors typically determine Black Diamond value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Black Diamond's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.